Veeva Systems (NYSE: VEEV)  announced that leaders from Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati, and Syneos Health are among the speakers at Veeva R&D and Quality Summit, June 6-7 in Madrid, Spain. Industry innovators will share how they leverage next-generation solutions to drive efficiencies that help deliver better patient outcomes.

Veeva R&D and Quality Summit will bring together more than 750 industry professionals to participate in over 40 sessions. Attendees will learn about strategies for developing the foundation for clinical operations and data in patient-centric trials, elevating quality management beyond compliance, streamlining regulatory processes, and improving oversight and efficiency in safety.

Featured keynotes and panel discussions include:

• Bayer outlining its regulatory journey to deliver a comprehensive view of approved content for a large and varied product portfolio.
• Boehringer Ingelheim highlighting its launch of a product development operating system for the future.
• LEO Pharma discussing the elevated role of safety as a strategic partner in product development.
• GSK, Recordati, and Syneos Health sharing their respective journeys to improve clinical trials.

"Our top priority is helping the industry deliver innovation that ensures the best possible outcomes for patients," says Rik Van Mol, senior vice president of Veeva Development Cloud. "Veeva R&D and Quality Summit offers industry leaders an ideal forum to connect, exchange ideas, and share strategies that will drive the industry forward."

The event is open exclusively to life sciences professionals. Register and stay up to date on the agenda and program details at veeva.com/eu/Summit.